Document Detail


Hypersexuality with antiparkinsonian therapy.
MedLine Citation:
PMID:  2575449     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thirteen parkinsonian patients drawn from two large parkinsonism clinics experienced hypersexuality as a consequence of anti-parkinsonian therapy. The cases include only those whose sexual behavior on treatment became a concern to the patient's family or a social agency. The majority of patients were men and had a relatively early onset of parkinsonian symptomatology. There was no relation between functional improvement and increased sexuality. Most patients showed some element of dose dependency between antiparkinsonian drugs and the hypersexual behavior. Prior sexual profile included from no sexual outlet to hypersexuality. Neither the prior history of psychiatric illness nor brain damage predisposed to such response on treatment, and in most patients, it was not a part of hypomania or a more diffuse psychiatric disturbance. We propose that hypersexuality on antiparkinsonian drugs is consequent to inhibition of prolactin secretion.
Authors:
R J Uitti; C M Tanner; A H Rajput; C G Goetz; H L Klawans; B Thiessen
Related Documents :
21038259 - Goal-directed imitation in patients with ideomotor apraxia.
9932949 - Influence of family history on clinical expression of tourette's syndrome.
17875619 - How do examiners and examinees think about role-playing of standardized patients in an ...
15492739 - Prevalence of psychosocial disturbances in children with nonorganic visual loss.
7829769 - Neuroendocrine responses to intravenous l-tryptophan in obsessive compulsive disorder.
11201349 - Help-seeking pathways among malay psychiatric patients.
17012439 - Dose escalation of the anti-tnf-alpha agents in patients with rheumatoid arthritis. a s...
17655679 - Reduction of p-wave duration and successful pulmonary vein isolation in patients with a...
2301219 - Interrelationship of variable coupling, multiformity and repetitive forms: implications...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical neuropharmacology     Volume:  12     ISSN:  0362-5664     ISO Abbreviation:  Clin Neuropharmacol     Publication Date:  1989 Oct 
Date Detail:
Created Date:  1990-03-13     Completed Date:  1990-03-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7607910     Medline TA:  Clin Neuropharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  375-83     Citation Subset:  IM    
Affiliation:
Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Aged
Amantadine / adverse effects,  therapeutic use
Dopamine Agents / adverse effects*,  therapeutic use
Female
Humans
Levodopa / adverse effects*,  therapeutic use
Male
Middle Aged
Parkinson Disease / drug therapy*
Phenethylamines / adverse effects*
Selegiline / adverse effects*,  therapeutic use
Sex Factors
Sexual Behavior / drug effects*
Chemical
Reg. No./Substance:
0/Dopamine Agents; 0/Levodopa; 0/Phenethylamines; 14611-51-9/Selegiline; 768-94-5/Amantadine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Altered release of growth hormone from dispersed adenohypophysial cells of streptozotocin diabetic r...
Next Document:  Effects of terguride in patients with Huntington's disease.